uu.seUppsala University Publications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Diagnostic Utility of Exome Sequencing for Kidney Disease
Hammer Hlth Sci, Dept Med, New York, NY USA.
Hammer Hlth Sci, Dept Med, New York, NY USA.
AstraZeneca Ctr Genom Res Precis Med & Genom, Innovat Med & Early Dev IMED Biotech Uni, Cambridge, England.
AstraZeneca Ctr Genom Res Precis Med & Genom, Innovat Med & Early Dev IMED Biotech Uni, Cambridge, England.
Show others and affiliations
2019 (English)In: New England Journal of Medicine, ISSN 0028-4793, E-ISSN 1533-4406, Vol. 380, no 2, p. 142-151Article in journal (Refereed) Published
Abstract [en]

BACKGROUND Exome sequencing is emerging as a first-line diagnostic method in some clinical disciplines, but its usefulness has yet to be examined for most constitutional disorders in adults, including chronic kidney disease, which affects more than 1 in 10 persons globally.

METHODS We conducted exome sequencing and diagnostic analysis in two cohorts totaling 3315 patients with chronic kidney disease. We assessed the diagnostic yield and, among the patients for whom detailed clinical data were available, the clinical implications of diagnostic and other medically relevant findings.

RESULTS In all, 3037 patients (91.6%) were over 21 years of age, and 1179 (35.6%) were of self-identified non-European ancestry. We detected diagnostic variants in 307 of the 3315 patients (9.3%), encompassing 66 different monogenic disorders. Of the disorders detected, 39 (59%) were found in only a single patient. Diagnostic variants were detected across all clinically defined categories, including congenital or cystic renal disease (127 of 531 patients [23.9%]) and nephropathy of unknown origin (48 of 281 patients [17.1%]). Of the 2187 patients assessed, 34 (1.6%) had genetic findings for medically actionable disorders that, although unrelated to their nephropathy, would also lead to subspecialty referral and inform renal management.

CONCLUSIONS Exome sequencing in a combined cohort of more than 3000 patients with chronic kidney disease yielded a genetic diagnosis in just under 10% of cases.

Place, publisher, year, edition, pages
2019. Vol. 380, no 2, p. 142-151
National Category
Urology and Nephrology
Identifiers
URN: urn:nbn:se:uu:diva-375897DOI: 10.1056/NEJMoa1806891ISI: 000455310300008PubMedID: 30586318OAI: oai:DiVA.org:uu-375897DiVA, id: diva2:1285367
Funder
AstraZenecaAvailable from: 2019-02-04 Created: 2019-02-04 Last updated: 2019-02-04Bibliographically approved

Open Access in DiVA

No full text in DiVA

Other links

Publisher's full textPubMed

Authority records BETA

Fellström, Bengt C.

Search in DiVA

By author/editor
Fellström, Bengt C.
By organisation
Renal Medicine
In the same journal
New England Journal of Medicine
Urology and Nephrology

Search outside of DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 79 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf